España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
Myriad Genetics
MYGN
NASDAQ
Watchlist
Leave a Comment
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$25.97
0
0.00%
Pre-Market: Jul 19, 4:00 PM EDT
15 minutes delayed
Get Report
Comment
Myriad Genetics (MYGN) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Myriad Genetics (NASDAQ:MYGN) Stock
Myriad Genetics Stock (NASDAQ: MYGN)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, July 11, 2024
Myriad Genetics And Personalis Announce Cross...
Benzinga Newsdesk
Tuesday, July 09, 2024
Myriad Genetics Secures Second Patent To Enha...
Benzinga Newsdesk
Thursday, June 27, 2024
Key Takeaways From Myriad Genetics Analyst Ratings
Benzinga Insights
Scotiabank Initiates Coverage On Myriad Genet...
Benzinga Newsdesk
Tuesday, June 11, 2024
Myriad Genetics Collaborates With GSK To Impr...
Benzinga Newsdesk
Tuesday, June 04, 2024
Myriad Genetics Launches New Universal Plus P...
Benzinga Newsdesk
Monday, June 03, 2024
Myriad Genetics Patient-Outcomes Study Valida...
Benzinga Newsdesk
Jefferies Assumes Myriad Genetics at Underper...
Benzinga Newsdesk
Thursday, May 30, 2024
QIAGEN And Myriad Genetics To Develop Globall...
Benzinga Newsdesk
Thursday, May 16, 2024
Myriad Genetics Study Published In JCO Precis...
Benzinga Newsdesk
Monday, May 13, 2024
Piper Sandler Maintains Neutral on Myriad Gen...
Benzinga Newsdesk
Wednesday, May 08, 2024
Leerink Partners Upgrades Myriad Genetics to ...
Benzinga Newsdesk
Why Upstart Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
Louisiana-Pacific Posts Upbeat Results, Joins Cricut, Elanco Animal, American Public Education And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Tuesday, May 07, 2024
Myriad Genetics Sees FY24 Adj. EPS $0.00-$0.0...
Benzinga Newsdesk
Myriad Genetics Q1 2024 Adj EPS $(0.01) Beats...
Benzinga Newsdesk
Myriad Genetics Announces Reorganization Of E...
Benzinga Newsdesk
Tuesday, April 16, 2024
New Myriad Genetics Published Study Demonstra...
Benzinga Newsdesk
Tuesday, April 09, 2024
Myriad Genetics Research Shows Reduction In H...
Benzinga Newsdesk
Friday, March 22, 2024
Reported Earlier, Myriad Genetics Granted Fou...
Benzinga Newsdesk
Wednesday, March 20, 2024
Myriad Genetics Says US Patent And Trademark ...
Benzinga Newsdesk
Tuesday, February 27, 2024
Myriad Genetics Sees 2024 Adj. EPS $0.00-$0.0...
Benzinga Newsdesk
Myriad Genetics: Q4 Earnings Insights
Benzinga Insights
Myriad Genetics Q4 2023 Adj EPS $0.04 Beats $...
Benzinga Newsdesk
Myriad Genetics And National Cancer Center Ho...
Benzinga Newsdesk
Earnings Scheduled For February 27, 2024
Benzinga Insights
Monday, February 26, 2024
Myriad Genetics Earnings Preview
Benzinga Insights
Tuesday, January 30, 2024
Goldman Sachs Maintains Buy on Myriad Genetic...
Benzinga Newsdesk
Monday, January 29, 2024
Peeling Back The Layers: Exploring Myriad Genetics Through Analyst Insights
Benzinga Insights
Goldman Sachs Maintains Buy on Myriad Genetic...
Benzinga Newsdesk
Friday, January 19, 2024
Myriad Genetics Acquires Precise Tumor, Preci...
Benzinga Newsdesk
Thursday, December 21, 2023
Genetic Testing Pioneer Myriad Genetics' Evolution Draws Analyst Attention Amid New Product(s) Anticipation
Vandana Singh
Myriad Genetics Appoints Of Scott Leffler As ...
Benzinga Newsdesk
Evaluating Myriad Genetics: Insights From 4 Financial Analysts
Benzinga Insights
Piper Sandler Initiates Coverage On Myriad Ge...
Benzinga Newsdesk
Wednesday, December 20, 2023
Myriad Genetics Establishes Comprehensive Pan...
Benzinga Newsdesk
Tuesday, December 19, 2023
Wells Fargo Initiates Coverage On Myriad Gene...
Benzinga Newsdesk
Thursday, December 14, 2023
Guggenheim Initiates Coverage On Myriad Genet...
Benzinga Newsdesk
Wednesday, December 13, 2023
Wolfe Research Initiates Coverage On Myriad G...
Benzinga Newsdesk
Monday, November 20, 2023
Myriad Genetics Celebrates One Million SneakP...
Benzinga Newsdesk
Friday, November 17, 2023
Myriad Genetics Agrees To Market The Personal...
Benzinga Newsdesk
Thursday, November 16, 2023
Myriad Genetics And Personalis Partner To Mar...
Benzinga Newsdesk
Thursday, November 09, 2023
Why AMC Entertainment Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
AerSale, Topgolf Callaway Brands, Digital Turbine And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Lisa Levin
Wednesday, November 08, 2023
Myriad Genetics Announced $100M Offering Of C...
Benzinga Newsdesk
Tuesday, November 07, 2023
JP Morgan Maintains Underweight on Myriad Gen...
Benzinga Newsdesk
Why Sanmina Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
Datadog, Tripadvisor, Myriad Genetics, Planet Fitness And Other Big Stocks Moving Higher On Tuesday
Lisa Levin
Monday, November 06, 2023
Myriad Genetics Q3 Adj EPS $(0.03) Beats $(0....
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch